Do Traders Think Procept Biorobotics Corp (PRCT) Can Keep Climbing Thursday?

Overall market sentiment has been high on Procept Biorobotics Corp (PRCT) stock lately. PRCT receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Procept Biorobotics Corp has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on PRCT!

See Full PRCT Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With PRCT Stock Today?

Procept Biorobotics Corp (PRCT) stock is up 1.62% while the S&P 500 is lower by -0.07% as of 2:07 PM on Thursday, Nov 30. PRCT has risen $0.60 from the previous closing price of $37.00 on volume of 321,120 shares. Over the past year the S&P 500 has gained 14.90% while PRCT is lower by -16.09%. PRCT lost -$2.33 per share in the over the last 12 months. To screen for more stocks like Procept Biorobotics Corp click here.

More About Procept Biorobotics Corp

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are primarily based in the United States. Its revenue is primarily generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces. Click Here to get the full Stock Report for Procept Biorobotics Corp stock.